Bill > AB542

This bill aims to create a new section in the Wisconsin statutes (146.348) that allows for the reimbursement of travel, ancillary costs, and other direct patient-incurred expenses related to participation in cancer clinical trials. The bill clarifies that such reimbursement is not considered an "undue inducement" to participate in these trials, as it is intended to eliminate financial barriers and create parity in access to clinical trials. The bill also requires sponsors of cancer clinical trials to provide potential patient-subjects with information about the availability of reimbursement for travel and ancillary costs, as well as for any family members, friends, or chaperones who may accompany the patient-subject. The legislative intent is to encourage diverse patient participation in cancer clinical trials by addressing the financial challenges that can prevent individuals from enrolling and completing these trials.

Health and Social Services

http://docs.legis.wisconsin.gov/2019/proposals/reg/asm/bill/ab542